Researchers Optimistic about Genomics Funding, Rate Illumina and Life Tech Best in Class | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Despite a gray forecast for National Institutes of Health funding, researchers have a relatively positive outlook on genomics funding, a recent survey conducted jointly by GenomeWeb and investment firm Mizuho Securities has found.

Respondents to the survey also ranked Illumina, Life Technologies, and Roche as the companies with the best products in genomics research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.